Biomarker Technologies
PrivateLast Round
Series B
May 1, 2015
Company Overview
Biomarker Technologies operates in Healthcare & Life Sciences and is based in Beijing. Its latest recorded funding round was a Series B round in May 2015.
Biomarker Technologies is a biotechnology company that provides multi-omics sequencing services and bioinformatics solutions for academic, clinical, and industrial research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Data Visualization
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biomarker Technologies Comparables
Compare Biomarker Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Novogene Co. Ltd. | 85% | |
| CD Genomics | 83% | |
| Macrogen Inc | 80% |
For institutional investors. Book with your work email.
Biomarker Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 1, 2015 | ||||
| Series A | Aug 1, 2013 |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2015
Completed Series B funding round.
- Aug 1, 2013
Completed a Series A funding round.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventNov 11, 2026
BMKGene attends CANVAS 2025 in Utah on Nov 11th '26, engaging attendees at Booth #420 with multi-omics solutions for agri-environmental science.
For institutional investors. Book with your work email.
Biomarker Technologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Biomarker Technologies's valuation, stock price, and market status.
Is Biomarker Technologies a public or private company?
Biomarker Technologies is a private company.
What is the current stock price of Biomarker Technologies?
Biomarker Technologies is a private company, so its shares have no public market price. Caplight tracks Biomarker Technologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Biomarker Technologies worth (valuation)?
Valuation information for Biomarker Technologies is not publicly available.
Can I buy Biomarker Technologies stock?
Biomarker Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Biomarker Technologies's last funding round?
Biomarker Technologies's most recent funding round was Series B on May 1, 2015.
Who are the main investors in Biomarker Technologies?
Investor information for Biomarker Technologies is not publicly disclosed.
Will Biomarker Technologies IPO soon?
No public IPO plans have been announced for Biomarker Technologies.
How can I track Biomarker Technologies secondary market activity?
Caplight tracks bids, offers, and trades in Biomarker Technologies's shares on secondary markets.